Sandeep A. Soni

Infectious Disease

15644 Pomerado Rd Ste 300
Poway, CA 92064

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy.

Gene Therapy for Sickle Cell Disease: Practice Recommendations from the American Society for Transplantation and Cellular Therapy and the International Society for Cell & Gene Therapy.

Journal: Transplantation and cellular therapy

Published: March 16, 2026

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.

Journal: Cytotherapy

Published: June 28, 2024

2023 Gene Therapy Mini-Series.

2023 Gene Therapy Mini-Series.

Journal: Cytotherapy

Published: January 18, 2023

Gene Therapies for Transfusion-Dependent b-Thalassemia.

Gene Therapies for Transfusion-Dependent b-Thalassemia.

Journal: Indian pediatrics

Published: March 27, 2021

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia.

Journal: The New England journal of medicine

Published: December 07, 2020

Gene therapies for transfusion dependent β-thalassemia: Current status and critical criteria for success.

Gene therapies for transfusion dependent β-thalassemia: Current status and critical criteria for success.

Journal: American journal of hematology

Published: February 10, 2020

A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study.

A Phase 2 Trial of KIR-Mismatched Unrelated Donor Transplantation Using in Vivo T Cell Depletion with Antithymocyte Globulin in Acute Myelogenous Leukemia: Children's Oncology Group AAML05P1 Study.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: July 23, 2019

Chemistry, manufacturing and controls for gene modified hematopoietic stem cells.

Chemistry, manufacturing and controls for gene modified hematopoietic stem cells.

Journal: Cytotherapy

Published: October 01, 2018

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.

Gene Therapy in Patients with Transfusion-Dependent β-Thalassemia.

Journal: The New England journal of medicine

Published: April 19, 2018

Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.

Unrelated Donor Transplantation in Children with Thalassemia using Reduced-Intensity Conditioning: The URTH Trial.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: December 03, 2017

Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.

Veno-occlusive disease after high-dose busulfan-melphalan in neuroblastoma.

Journal: Bone marrow transplantation

Published: August 28, 2017

Outcomes of Unrelated Donor Stem Cell Transplantion with Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients with Severe Sickle Cell Disease.

Outcomes of Unrelated Donor Stem Cell Transplantion with Post-Transplant Cyclophosphamide for Graft-versus-Host Disease Prophylaxis in Patients with Severe Sickle Cell Disease.

Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation

Published: August 02, 2017

Showing 1-12 of 19

Last Updated: 09/26/2026